바로가기메뉴

본문 바로가기 주메뉴 바로가기

Association of Mycoplasma pneumoniae in Asthma Pathogenesis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.65 no.4, pp.261-268
Mohammed Ali M. Marie (Clinical Laboratory Department, Riyadh College of Health Sciences, King Saud University, Riyadh, Kin)
  • Downloaded
  • Viewed

Abstract

The role of atypical bacterial infection in the pathogenesis of asthma is a subject of continuing debate. There is an increasing body of literature concerning the association between the atypical bacteria such as Mycoplasma pneumoniae (M. pneumoniae) and asthma pathogenesis. Moreover, many studies investigating such a link have been uncontrolled and have provided conflicting evidence, in part due to the difficulty in accurately diagnosing infection with these atypical pathogens. This manuscript will review the relationship between M. pneumoniae infection and asthma pathogenesis

keywords
Mycoplasma pneumoniae, Asthma, Pathogenesis, Antimicrobial, Diagnosis

Reference

1.

Johnston SL, (1996) The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis, Am J Respir Crit Care Med

2.

Lemanske RF Jr, (2003) Is asthma an infectious disease, Chest

3.

Fireman P, (2003) Understanding asthma pathophysiology, Allergy Asthma Proc

4.

Bleecker ER, (1997) Evidence for multiple genetic susceptibility loci for asthma, Am J Respir Crit Care Med

5.

Kroegel C, (1997) Is there a place for intrinsic asthma as a distinct immunopathological entity, Eur Respir J

6.

von HL, (2002) severity of asthma: focus on Chlamydia pneumoniae, Eur Respir J

7.

Holgate ST, (1999) The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma, Clin Exp Allergy

8.

Barnes PJ, (2008) Chapter 248. Asthma. In Harrison's principles of internal medicine, McGraw-Hill Co, Inc.

9.

Vervloet LA, (2007) Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias, Braz J Infect Dis

10.

Lieberman D, (1996) Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients, Respiration

11.

Daxboeck F, (2003) Laboratory diagnosis of Mycoplasma pneumoniae infection, Clin Microbiol Infect

12.

van Kuppeveld FJ, (1992) Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification, Appl Environ Microbiol

13.

Kleemola SR, (1990) Rapid diagnosis of Mycoplasma pneumoniae infection: clinical evaluation of a commercial probe test, J Infect Dis

14.

Uldum SA, (1992) SØndergård-Andersen J, Lind K. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae, J Clin Microbiol

15.

Sillis M, (1993) Modern methods for the diagnosis of Mycoplasma pneumoniae pneumonia, Rev Med Microbiol

16.

Luneberg E, (1993) Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates, J Clin Microbiol

17.

Guleria R, (2005) Mycoplasma pneumoniae and central nervous system complications: a review, J Lab Clin Med

18.

Waites KB, (2004) Mycoplasma pneumoniae and its role as a human pathogen, Clin Microbiol Rev

19.

Freymuth F, (1999) Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children, J Clin Virol

20.

Biscardi S, (2004) Mycoplasma pneumoniae and asthma in children, Clin Infect Dis

21.

Esposito S, (2002) Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze, Pediatr Pulmonol

22.

Schwarze J, (2000) Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization, Am J Respir Crit Care Med

23.

Martin RJ, (2001) A link between chronic asthma and chronic infection, J Allergy Clin Immunol

24.

Gil JC, (1993) Isolation of Mycoplasma pneumoniae from asthmatic patients, Ann Allergy

25.

Thumerelle C, (2003) Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France), Pediatr Pulmonol

26.

Seggev JS, (1986) Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults, Ann Allergy

27.

Meloni F, (2004) Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations, J Chemother

28.

Lieberman D, (2003) Atypical pathogen infection in adults with acute exacerbation of bronchial asthma, Am J Respir Crit Care Med

29.

Kraft M, (1998) Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma, Am J Respir Crit Care Med

30.

Tuuminen T, (2004) Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma, Clin Microbiol Infect

31.

Johnston SL, (2005) Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis, Am J Respir Crit Care Med

32.

Martin RJ, (2001) Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model, Am J Respir Cell Mol Biol

33.

Hoek KL, (2002) Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells, J Allergy Clin Immunol

34.

Koh YY, (2001) Levels of interleukin-2, interferon-gamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production, Pediatrics

35.

Yang J, (2002) Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae, Infect Immun

36.

Chu HW, (2003) Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice, Infect Immun

37.

Opitz O, (1996) Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response, Immunobiology

38.

Waites KB, (2003) In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas, Antimicrob Agents Chemother

39.

Clyde WA Jr, (1979) Mycoplasma pneumonaie infections of man. In The mycoplasmas II. Human and animal mycoplasmas, vol. II, Academic Press

40.

Kenny GE, (2001) Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin- dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones, Antimicrob Agents Chemother

41.

Schonwald S, (1999) Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome: a randomized study, Infection

42.

Waites KB, (2003) In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas, Antimicrob Agents Chemother

43.

Pullman J, (2003) Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults, Int J Clin Pract

Tuberculosis & Respiratory Diseases